Article ; Online: Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19.
Travel medicine and infectious disease
2020 Volume 37, Page(s) 101678
MeSH term(s) | Adenosine Monophosphate/analogs & derivatives ; Alanine/analogs & derivatives ; Antibodies, Monoclonal, Humanized ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/drug therapy ; Coronavirus Infections/epidemiology ; Humans ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2 ; Severe Acute Respiratory Syndrome ; COVID-19 Drug Treatment |
---|---|
Chemical Substances | Antibodies, Monoclonal, Humanized ; remdesivir (3QKI37EEHE) ; Adenosine Monophosphate (415SHH325A) ; tocilizumab (I031V2H011) ; Alanine (OF5P57N2ZX) |
Keywords | covid19 |
Language | English |
Publishing date | 2020-04-20 |
Publishing country | Netherlands |
Document type | Letter ; Comment |
ZDB-ID | 2170891-5 |
ISSN | 1873-0442 ; 1477-8939 |
ISSN (online) | 1873-0442 |
ISSN | 1477-8939 |
DOI | 10.1016/j.tmaid.2020.101678 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6236: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.